Science Explorer Interactive view Map
Company · Trenton · United States

Ono Pharmaceutical (United States)

In research, Ono Pharmaceutical (United States) stands highest in Medicine (#7,538 of 10,443 worldwide) and Health Sciences (#9,298 of 11,982 worldwide), 2022–2025.

ono.co.jp/engROR OpenAlex
World rank, 2022–2025
#13,924
of 28,054 · #5,237 all time
Rank in United States
#1,943
of 4,192
Research works
1.3k
▲ 26% vs 2013–17
Citations
41k
31.4 per fractional work
Top-10% rate
15.0%
record average 16.5%
Open access
26%
world 28%

What is Ono Pharmaceutical (United States) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #7,538 of 10,443 14.0%61 #6968
Health SciencesDomain #9,298 of 11,982 14.0%63 #9322

Each strip is that field’s whole ranked pool, with the notch where Ono Pharmaceutical (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.69× its world share, 15 worksBiochemistry, Geneti…Immunology and Microbiology: 5.04× its world share, 5 worksImmunology and Micro…Neuroscience: 0.33× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.07× its world share, 3 worksPharmacology, Toxico…Chemistry: 1.56× its world share, 3 worksChemistryComputer Science: 0.23× its world share, 2 worksComputer ScienceEngineering: 0.17× its world share, 3 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.35× its world share, 1 worksMaterials ScienceMathematics: 1.19× its world share, 2 worksMathematicsPhysics and Astronomy: 0.03× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.68× its world share, 2 worksHealth ProfessionsMedicine: 2.97× its world share, 61 worksMedicineNursing: 0.24× its world share, 0 worksNursingVeterinary: 0.33× its world share, 0 worksVeterinaryArts and Humanities: 0.08× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.04× its world share, 0 worksBusiness, Management…Decision Sciences: 0.29× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.17× its world share, 5 worksEconomics, Econometr…Psychology: 0.18× its world share, 1 worksPsychologySocial Sciences: 0.13× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.1×. Every wedge is a field page.

Who are the top researchers at Ono Pharmaceutical (United States)?

Ranked on the composite score, W. Philippoff, Fernando Dangond and D. Ezcurra lead among researchers whose main affiliation is Ono Pharmaceutical (United States).

  1. 1 W. Philippoff United States · #117,730 worldwide 279 citations · 30 works
  2. 2 Fernando Dangond United States · #321,563 worldwide 97 citations · 20 works
  3. 3 D. Ezcurra United States · #512,940 worldwide 68 citations · 26 works
  4. 4 Robert E. Eckardt United States · #576,962 worldwide 16 citations · 23 works
  5. 5 Amy Phillips United States · #1,065,220 worldwide 4 citations · 19 works
  6. 6 R Cirillo United States · #1,150,124 worldwide 25 citations · 22 works
All ranked researchers at Ono Pharmaceutical (United States)

Which keywords describe research at Ono Pharmaceutical (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Molecular Characterization, Neoadjuvant Therapy, Clinical Trials, Targeted Therapy, Guidelines and Bladder Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy12▲ 16×13 topics
  2. Immunotherapy10▲ 13×11 topics
  3. Molecular Characterization8▲ 41×4 topics
  4. Neoadjuvant Therapy7▲ 28×5 topics
  5. Clinical Trials6▲ 8.7×8 topics
  6. Targeted Therapy6▲ 25×4 topics
  7. Bladder Cancer6▲ 147×1 topic
  8. Guidelines6▲ 12×2 topics
  9. Tumor Microenvironment6▲ 12×7 topics
  10. Urothelial Carcinoma6▲ 127×1 topic
  11. Cancer6▲ 4.0×20 topics
  12. Inflammation6▲ 2.6×21 topics
  13. Prognostic Factors5▲ 11×7 topics
  14. Machine Learning5▲ 1.45×11 topics
  15. Quality of Life5▲ 3.0×9 topics
  16. Monoclonal Antibodies4▲ 44×3 topics
  17. Cancer Therapy4▲ 6.7×11 topics
  18. Glycosylation3▲ 28×3 topics
  19. Therapeutic Antibodies3▲ 45×2 topics
  20. Autoantibodies3▲ 13×6 topics
  21. Immune Checkpoint Blockade3▲ 26×1 topic
  22. PD-1 and PD-L13▲ 26×1 topic
  23. Genomic Instability3▲ 25×3 topics
  24. ALK Inhibitors3▲ 43×1 topic
  25. EGFR Mutations3▲ 43×1 topic
  26. Genomic Profiling3▲ 27×2 topics
  27. Pharmacokinetics3▲ 10×4 topics
  28. Cell Death3▲ 11×5 topics
  29. Precision Medicine3▲ 5.6×4 topics
  30. Antibody Engineering3▲ 44×1 topic
  31. Fc Receptors3▲ 44×1 topic
  32. Homologous Recombination2▲ 52×2 topics
  33. Metastasis2▲ 6.8×8 topics
  34. Cancer Incidence2▲ 17×3 topics
  35. Cognitive Impairment2▲ 8.9×5 topics
  36. Cost-effectiveness Analysis2▲ 26×1 topic
  37. Health Utility Measures2▲ 26×1 topic
  38. Cell-Free DNA2▲ 21×2 topics
  39. Toll-like Receptors2▲ 18×2 topics
  40. Therapeutic Targets2▲ 13×4 topics

Which research topics does Ono Pharmaceutical (United States) publish most on?

By volume in 2022–2025: Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Monoclonal and Polyclonal Antibodies Research.

Bladder and Urothelial C…6Bladder and Urothelial Cancer Treatments: 6 fractional worksCancer Immunotherapy and Biomarkers: 3 fractional worksLung Cancer Treatments a…3Lung Cancer Treatments and Mutations: 3 fractional worksMonoclonal and Polyclona…3Monoclonal and Polyclonal Antibodies Research: 3 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 2 fractional worksEconomic and Financial Impacts of Cancer: 2 fractional worksMultiple Sclerosis Resea…2Multiple Sclerosis Research Studies: 2 fractional worksSystemic Lupus Erythematosus Research: 2 fractional worksCancer Genomics and Diagnostics: 2 fractional worksComputational Drug Discovery Methods: 2 fractional works
SurgeryOncologyPulmonary and Respiratory MedicineRadiology, Nuclear Medicine and Imaging5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Bladder and Urothelial Cancer Treatments Surgery 6 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 3 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  6. 6 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
  7. 7 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 2 works
  8. 8 Systemic Lupus Erythematosus Research Rheumatology 2 works
  9. 9 Cancer Genomics and Diagnostics Cancer Research 2 works
  10. 10 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available26.3%not open73.7%

World: 28% of research is openly available.

with international co-authors26.0%domestic only74.0%

World: 19% is written across borders.

How has Ono Pharmaceutical (United States)'s research output changed?

Output in 2018–2022 was 26% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Trenton

All research institutions in Trenton

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.